CRDF

CARDIFF ONCOLOGY INC

CRDF·14147L108·US·Common Stock·Healthcare - Biotechnology-13D/G

CRDF (CARDIFF ONCOLOGY INC) is held by 62 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($3.8M), FRANKLIN RESOURCES INC ($1.6M), BlackRock, Inc. ($1.3M). Net institutional sentiment: Mixed.

62
Holders
(8 Elite)
$15M
Total Value
43% (72)
Consensus
31 buying - 41 selling
13F: Insider & Congress: Updated regularly
CRDF

Smart Money Verdict

View all
Loading verdict
Held by 62 funds
8 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Jul 16, 2026 · Activists Jul 27, 2026 · Congress none

ActivistBlackRock, Inc.BlackRock, Inc.1.3%Jul 27, 2026
InsiderMMMohindru ManiBuy $50KJul 14, 2026
InsiderPWPACE GARY WBuy $1000KJul 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.9M(+1.4%)$3.8M0.0%-47.71%
27
Unchanged
1.2M$1.6M0.0%-65.71%
0
Decreased
972,873(-75.6%)$1.3M0.0%-75.07%
0
Decreased
912,513(-1.1%)$1.2M0.0%-70.38%
0
Decreased
820,062(-48.7%)$1.1M0.0%-76.41%
0
Increased
638,699(+59.5%)$830,3090.0%-47.66%
36
Increased
607,900(+1415.8%)$790,2700.0%-27.18%
40
Decreased
410,602(-8.0%)$533,7830.0%-47.93%
0
Increased
346,353(+423.5%)$450,2600.0%-30.34%
39
Decreased
331,395(-72.1%)$430,8140.0%-59.39%
0
Increased
246,095(+337.1%)$319,9240.0%-38.89%
26
Increased
228,461(+1647.2%)$296,9990.0%-30.46%
38
New
162,214$210,8790.0%-24.30%
32
Decreased
161,689(-46.7%)$210,1960.0%-68.54%
0
Decreased
152,875(-69.0%)$198,7380.0%-71.49%
0
Increased
134,517(+484.1%)$174,8720.0%-38.37%
36
New
125,550$163,2150.0%-24.30%
31
Decreased
120,827(-10.9%)$157,0760.0%-59.77%
0
Increased
116,138(+25.8%)$150,9790.0%-53.45%
19
Decreased
97,400(-61.1%)$126,6200.0%-65.02%
0

Showing 1-20 of 81

1 / 5
CRDFCRDFCARDIFF ONCOLOGY INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used